Novel Cognitive Markers for Early Diagnosis and Monitoring of Progressive Supranuclear Palsy
Objective: The aim of this study was to evaluate whether a novel computerised test could offer an inexpensive and reliable tool that can aid diagnosis…Unusual Progressive Supranuclear Palsy: a case report
Objective: Introduction: Progressive supranuclear palsy (PSP) is a rare brain condition. It is predominantly a sporadic disease that occurs between 45 and 75 years of…Predictors of survival in Progressive Supranuclear Palsy in a Tunisian cohort
Objective: To investigate survival and its determinants in a Tunisian cohort of Progressive Supranuclear Palsy (PSP). Background: PSP is a neurodegenerative tauopathy characterized by faster…Early detection of change in motor and cognitive symptoms in a longitudinal Progressive Supranuclear Palsy cohort – the OxQUIP study.
Objective: We aimed to determine longitudinal changes in motor and cognitive features of Progressive Supranuclear Palsy using multiple closely spaced follow-up timepoints over a period…Automated Midbrain-Pons Ratio using Artificial Intelligence Differentiates PSP from other Atypical Parkinsonian Disorders
Objective: Our primary goal was to implement an automated measure of the midbrain to pons ratio (MPR) using an artificial intelligence method. Our second objective…The loss of skeletal muscle mass in progressive supranuclear palsy
Objective: To investigate body composition parameters, focusing on skeletal muscle mass, in patients with progressive supranuclear palsy (PSP) and compared them with those of healthy…A retrospective review of clinical and MRI/CT radiological correlation in progressive supranuclear palsy (PSP)
Objective: To investigate the clinical and MRI/CT radiological correlation to improve the diagnosis and management of PSP Background: PSP is a rare progressive neurodegenerative disease…Plasma microRNA expression profiling in patients with progressive supranuclear palsy. A five-microRNA panel in plasma was identified as a potential biomarker for progressive supranuclear palsy
Objective: Our objective was to identify differentially expressed, circulating miRNAs in PSP which could serve as diagnostic biomarker for this disease. Background: Progressive supranuclear palsy…Quantitative susceptibility mapping and blood neurofilament light chain differentiate between parkinsonian disorders
Objective: We employed Quantitative susceptibility mapping (QSM) to assess iron deposition in a larger sample size and explore whether combining QSM and NfL can improve…A Rare Case of Reversible Acute Parkinsonism in Fulminant HIV Encephalopathy
Objective: - Background: HIV infection of the central nervous system can be a result of direct neuroinflammatory processes or by opportunistic infections. Movement disorders in…
- « Previous Page
- 1
- …
- 752
- 753
- 754
- 755
- 756
- …
- 1734
- Next Page »